Abstract:Steroid receptor coactivator 3 (SRC-3, amplified in breast cancer 1, or ACTR) is a transcriptional coactivator for nuclear receptors and certain other transcription factors such as E2F1. SRC-3 is overexpressed in breast cancers, and its overexpression is sufficient to cause mammary carcinomas in vivo. However, the mechanisms controlling endogenous SRC-3 overexpression are unknown. In this study, we identified the first exon and analyzed the 5' regulatory sequence of the SRC-3 gene. We found three evolutionarily conserved regions (ECRs) in the 5' SRC-3 regulatory sequence, and ECR2 makes a major contribution to the SRC-3 promoter activity. The ECR2 region (bp -250/+350) contains several specificity protein 1 (Sp1) binding sites and two E2F1 binding sites. We show that E2F1 can significantly activate the ECR2 promoter activity in a dose-dependent manner. Furthermore, overexpression of E2F1 significantly increases the promoter activity of the endogenous SRC-3 gene and boosts SRC-3 expression in vivo. Conversely, knockdown of E2F1 reduces SRC-3 expression. We demonstrate that the mechanism of E2F1 activity on SRC-3 promoter is independent of the E2F binding sites but relies on the Sp1 element located at bp +150/+160. Sp1, E2F1, and SRC-3 are specifically recruited to this Sp1 site and the interaction between E2F1 and Sp1 is essential to modulate SRC-3 expression. Moreover, SRC-3 coactivates E2F1 activity and thereby additively stimulates a further increase in SRC-3 expression in vivo. These results suggest that in cells with hyperactive E2F1, such as the case encountered in breast cancer cells, there is a positive feedback regulatory loop consisting of E2F1 and SRC-3 to maintain high levels of SRC-3 and E2F1 activity, which may partially interpret the oncogenic role of SRC-3 overexpression.

Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology

A SNP in Steroid Receptor Coactivator-1 Disrupts a GSK3β Phosphorylation Site and is Associated with Altered Tamoxifen Response in Bone.

Ablation of steroid receptor coactivator-3 in mice impairs adipogenesis and enhances energy expenditure

Essential Phosphatases and A Phospho-Degron Are Critical for Regulation of Src-3/Aib1 Coactivator Function and Turnover

An Essential Function of the SRC-3 Coactivator in Suppression of Cytokine Mrna Translation and Inflammatory Response

The Steroid Receptor Coactivator SRC-3 (P/cip/rac3/aib1/actr/tram-1) is Required for Normal Growth, Puberty, Female Reproductive Function, and Mammary Gland Development.

Regulation of SRC family coactivators by post-translational modifications.

Inhibition of Syk Promotes Chemical Reprogramming of Fibroblasts Via Metabolic Rewiring and H2 S Production.

Steroid receptor coactivator 3 ( SRC-3 / AIB1 ) is enriched and functional in mouse and human Tregs

SRC-3 Has a Role in Cancer Other Than As a Nuclear Receptor Coactivator

SRC-3, a Steroid Receptor Coactivator: Implication in Cancer

Deletion of Steroid Receptor Coactivator-3 Gene Ameliorates Hepatic Steatosis

Data from the Steroid Receptor Coactivator-3 is Required for the Development of Castration-Resistant Prostate Cancer

Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2

SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

Review of the in vivo functions of the p160 steroid receptor coactivator family.

Steroid Receptor Coactivator 3 Regulates Synaptic Plasticity and Hippocampus-dependent Memory

The SRC-3/AIB1 Coactivator is Degraded in a Ubiquitin- and ATP-Independent Manner by the REGγ Proteasome

Stimulation of Steroid Receptor Coactivator-3 (SRC-3) Gene Overexpression by a Positive Regulatory Loop of E2F1 and SRC-3.

Differential Gene Regulation by the SRC Family of Coactivators.

SMRT Regulates Metabolic Homeostasis and Adipose Tissue Macrophage Phenotypes in Tandem